ClinicalTrials.gg
Status unknownNCT04895111Updated Oct 27, 2023

Endobronchial Ultrasound Strain Elastography in Sarcoidosis

An observational study in Sarcoidosis, Pulmonary, sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Status unknown at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-27.

Sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Observational

The sponsor has not verified this record recently (last verified Aug 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
701
Ages
18 Years and older
Sex
All
01

Study summary

Strain elastography (SE) is an imaging method used for the measurement of relative tissue elasticity through qualitative (color pattern) or semi-quantitative methods (strain ratio or strain histogram). Very recently, the first pilot study has provided preliminary evidence that EBUS-SE elastography may help identify fibrotic lymph nodes in sarcoidosis and that sampling lymph nodes characterized by low strain elastography, that is "stiff" nodes, is associated with an increased risk of retrieving an inadequate sample (i.e. a sample which is not representative of the lymph node tissue). The investigators hypothesize that an EBUS-SE pattern indicative of lymph node stiffness will be associated with less granulomas and more fibrosis.

Read the detailed description

In the last decade, the possibility to sample under ultrasound guidance (endosonography) the intrathoracic lymph nodes through the airways (endobronchial ultrasound guided, EBUS-TBNA) or through the oesophagus (endoscopic ultrasound-guided fine needle aspiration, EUS-FNA/EUS-b-FNA) has revolutionized the diagnostic approach to sarcoidosis. Individual studies and meta-analyses performed in selected and unselected patient populations have shown that EBUS and EUS both have overall diagnostic accuracy exceeding 80%. In addition, endosonography provides useful information about lymph node density; indeed, the presence of inhomogeneity in the lymph node texture on B-mode during endosonography represents the most important factor favouring infection over sarcoidosis in patients with lymphadenopathy.

Although the diagnostic success rate of EBUS-TBNA in detecting granulomas in lymph nodes of patients with suspected sarcoidosis is very high, the procedure is not foolproof and tends to have a lower yield in stages II/III as compared to stage I disease. Clinical experience suggests that at least some of the false-negative EBUS-TBNA results in sarcoidosis patients may be caused by the presence of lymph nodes with extensive fibrosis. We aim to evaluate whether EBUS-SE may help identify fibrotic lymph nodes in sarcoidosis and if the outcome of EBUS-TBNA is different in lymph nodes for which EBUS-SE suggest high fibrotic content.

02

Conditions studied

  • Sarcoidosis, Pulmonary

Keywords

  • Sarcoidosis
  • Endobronchial Ultrasound
  • Elastography
  • Endosonography
  • Granuloma
03

In context

Sarcoidosis, Pulmonary

67 studies on the registry are indexed under Sarcoidosis, Pulmonary; 17 are open to participants now.

This study's planned enrollment of 701 is above the median of 100 across 15 observational studies indexed under Sarcoidosis, Pulmonary.

Browse Sarcoidosis, Pulmonary studies →

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is the lead sponsor of 948 studies on the registry; 537 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients with a clinical and radiological suspect of sarcoidosis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • ASA physical status I-III.
  • Clinical/radiological (computed tomography) suspicion of sarcoidosis (Stages I to III)

Exclusion criteria

Exclusion Criteria:

  • Inability or unwillingness to consent.
  • Severe bleeding disorders
  • Contraindication for temporary interruption of the use of anticoagulant or antiplatelet therapy different from aspirin.
  • Recent and/or uncontrolled cardiac disease, uncontrolled pulmonary hypertension.
  • Compromised upper airway (eg, concomitant head and neck cancer or central airway stenosis for any reason).
  • Pregnancy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
701 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients with suspected sarcoidosis

    Consecutive patients with clinical and radiological (CT scan +/- PET) suspect of sarcoidosis

    Diagnostic Test: Endobronchial ultrasound strain elastography

Interventions

  • Diagnostic testEndobronchial ultrasound strain elastography

    Measurement of tissue elasticity of hilar and mediastinal lymph nodes through strain elastography measured during an endonbronchial ultrasound examination

06

What researchers measure

Primary outcomes

  1. • Diagnostic yield for the detection of granulomas on endosonography samples according to a mean value of the strain histogram <40 or ≥40

    The diagnostic yield for the detection of granulomas will be measured on a per lymph node basis (number of lymph nodes in which the pathological exam of endosonography samples identifies granulomas/number of lymph nodes submitted to endosonography)

    Time frame: 15 days

Secondary outcomes

  1. • Adequacy of endosonography samples according to a mean value of the strain histogram <40 or ≥40.

    The adequacy will be measured on a per lymph node basis (number of lymph nodes in which the pathological exam shows an adequate endosonography sample/number of lymph nodes submitted to endosonography) and is defined as the presence of a preponderance of lymphocytes at the pathological exam of the endosonography sample.

    Time frame: 15 days

  2. • Correlation between the strain elastography pattern measured with the mean value of the strain histogram and the following variables: age, sex, sarcoidosis stage (I vs II vs III), duration of sarcoidosis-related symptoms.

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04895111
Responsible party
Sponsor
First posted
May 20, 2021
Start date
May 10, 2021
Primary completion
Sep 30, 2023
Completion
Mar 31, 2024 (estimated)
Last update
Oct 27, 2023

Study contacts

Rocco Trisolini, MD
Contact
rocco.trisolini@policlinicogemelli.it
+390630154204
Fausto Leoncini, MD
Contact
fausto.leoncini@policlinicogemelli.it

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion